Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Antibiotic Resistance
U.K. researchers use deep learning to develop rapid antimicrobial resistance test
Researchers are hailing progress toward more rapid detection of antimicrobial resistance (AMR), with a susceptibility test returning results in 30 minutes.
December 1, 2023
Day Zero Diagnostics to use $16M in funding to improve management of antibiotic-resistant infections
Day Zero Diagnostics recently raised $16 million to fund the application of whole-genome sequencing and artificial intelligence to antibiotic-resistant infections, facilitating the firm’s goal of changing how infectious diseases are diagnosed.
September 28, 2023
Magnolia Medical Technologies publishes survey report on hospitalization risks
The greatest concern about hospitalization among the 1,002 adults in the U.S. surveyed was the high cost, which outpaced concerns about antimicrobial-resistant bacterial infections, sepsis, hospital-acquired infections, and other risks.
July 26, 2023
Hospitals advised to rethink antibiotic use under new MRSA prevention guidance
The document, which will be published in the journal Infection Control & Hospital Epidemiology, represents the latest thinking on the prevention of methicillin-resistant Staphylococcus aureus (MRSA).
June 28, 2023
Studies show Pathnostics UTI test required fewer resources, reduced costs compared to standard testing
In the study, the average one-year costs related to UTIs were $501.85 lower for patients receiving treatment based on the Guidance test than for those receiving treatment based on the traditional culture test.
June 20, 2023
Seegene, Werfen partnering to develop syndromic qPCR assays
The partnership, executed through Seegene's OneSystem initiative, would lead to the joint development of syndromic qPCR assays suitable for the Spanish and Portuguese healthcare systems.
June 14, 2023
Sorrento Therapeutics awarded $4.6M to develop emerging disease diagnostic platform
Under a U.S. government contract, the firm will aim to develop a platform for the rapid and sensitive detection of proteins and other biomolecules.
June 13, 2023
Metagenomics study finds antibiotic resistance genes are widespread among bacteria
Bacteria everywhere carry previously unknown genes that make them resistant to antibiotics, potentially aggravating the problem of untreatable bacterial infections.
June 6, 2023
Asep Medical Holdings aims for Nasdaq listing
Sepset Biosciences, an Asep Medical business, is preparing for clinical studies aimed at the commercialization of a diagnostic test. The test leverages gene expression to predict the development of severe sepsis.
May 31, 2023
FDA clears Becton Dickinson MRSA imaging software
The software leverages AI to automate the traditionally labor- and time-intensive task of inspecting Petri dishes to determine whether there is bacterial growth.
May 16, 2023
U.K. IVD market grows to $4.6 billion; Brexit not a factor
The U.K. market is expected to grow just under 3% per year for the next five years, the report said, faster than Italy, France, or the Netherlands, and at about the same rate as Germany.
May 4, 2023
Antibiotic susceptibility test in study reveals current antibiotics may cure superbugs
The test revealed that some of the commercial, FDA-approved antibiotics can treat drug-resistant superbug infections.
May 1, 2023
Page 1 of 3
Next Page
